• F. Colland (Inventor)
  • N. Barker (Inventor)
  • J.C. Clevers (Inventor)
  • E. Gomez (Inventor)
  • M. Lambertus (Inventor)
  • E.S. Suils (Inventor)
The present invention relates to the use of inhibitors of the expressed proteins of TCF target genes whose expression is regulated by TCF/.beta.-catenin complexes for the preparation of a therapeutical composition for the treatment of cancers in which TCF/.beta.-catenin signalling is deregulated. Such inhibitors can be antibodies, small molecules, antisense RNA and dsRNA for use in RNAi. The invention also relates to these inhibitors per se.
Original languageEnglish
Publication date2006

ID: 429480